Corvus Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Corvus Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q2 2024.
  • Corvus Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $717K.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $717K Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.08M Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.43M Dec 31, 2023 10-Q 2024-08-06
Q3 2022 $3.15M -$1.29M -29.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.48M +$1.55M +80.1% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.8M +$1.56M +69.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $4.13M +$1.57M +61.2% Dec 31, 2021 10-Q 2022-11-03
Q3 2021 $4.44M +$1.59M +55.8% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $1.93M -$1.21M -38.5% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $2.24M -$1.19M -34.6% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $2.56M -$1.16M -31.2% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $2.85M -$1.15M -28.8% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $3.14M -$1.14M -26.7% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $3.43M -$1.13M -24.9% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $3.72M Dec 31, 2019 10-K 2021-03-25
Q3 2019 $4M Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $4.28M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $4.56M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.